SlateStone Wealth’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.1M | Sell |
117,597
-4,937
| -4% | -$578K | 1.16% | 23 |
|
|
2026
Q1 | $14.7M | Buy |
122,534
+3,147
| +3% | +$363K | 1.22% | 22 |
|
|
2025
Q4 | $12.6M | Buy |
119,387
+477
| +0.4% | +$44.8K | 1.05% | 26 |
|
|
2025
Q3 | $9.98M | Buy |
118,910
+875
| +0.7% | +$72.1K | 0.86% | 36 |
|
|
2025
Q2 | $9.34M | Buy |
118,035
+2,284
| +2% | +$182K | 0.87% | 38 |
|
|
2025
Q1 | $10.4M | Buy |
115,751
+1,890
| +2% | +$176K | 1.04% | 31 |
|
|
2024
Q4 | $11.3M | Buy |
113,861
+1,251
| +1% | +$129K | 1.11% | 24 |
|
|
2024
Q3 | $12.8M | Buy |
112,610
+35,321
| +46% | +$4.2M | 1.15% | 20 |
|
|
2024
Q2 | $9.57M | Sell |
77,289
-30,810
| -29% | -$3.97M | 1.04% | 21 |
|
|
2024
Q1 | $14.3M | Buy |
108,099
+33,541
| +45% | +$4.13M | 1.43% | 13 |
|
|
2023
Q4 | $8.13M | Buy |
74,558
+4,228
| +6% | +$439K | 1.05% | 23 |
|
|
2023
Q3 | $7.24M | Buy |
70,330
+29,210
| +71% | +$3.15M | 1.05% | 24 |
|
|
2023
Q2 | $4.75M | Sell |
41,120
-970
| -2% | -$110K | 0.89% | 26 |
|
|
2023
Q1 | $4.48M | Buy |
42,090
+4,408
| +12% | +$476K | 0.93% | 21 |
|
|
2022
Q4 | $4.18M | Buy |
37,682
+1,432
| +4% | +$146K | 1.01% | 22 |
|
|
2022
Q3 | $3.12M | Buy |
36,250
+305
| +0.8% | +$27.2K | 0.83% | 25 |
|
|
2022
Q2 | $3.28M | Buy |
35,945
+3,872
| +12% | +$343K | 0.84% | 29 |
|
|
2022
Q1 | $2.63M | Buy |
32,073
+10,582
| +49% | +$834K | 0.59% | 41 |
|
|
2021
Q4 | $1.65M | Sell |
21,491
-221
| -1% | -$17.6K | 0.35% | 64 |
|
|
2021
Q3 | $1.63M | Sell |
21,712
-500
| -2% | -$38K | 0.37% | 62 |
|
|
2021
Q2 | $1.73M | Sell |
22,212
-2,984
| -12% | -$222K | 0.39% | 63 |
|
|
2021
Q1 | $1.85M | Buy |
25,196
+19,267
| +325% | +$1.42M | 0.46% | 55 |
|
|
2020
Q4 | $463K | Sell |
5,929
-365
| -6% | -$27.9K | 0.12% | 123 |
|
|
2020
Q3 | $498K | Sell |
6,294
-388
| -6% | -$30.4K | 0.11% | 131 |
|
|
2020
Q2 | $493K | Sell |
6,682
-21,256
| -76% | -$1.6M | 0.11% | 131 |
|
|
2020
Q1 | $2.05M | Sell |
27,938
-1,686
| -6% | -$133K | 0.58% | 46 |
|
|
2019
Q4 | $2.57M | Buy |
29,624
+3,759
| +15% | +$309K | 0.59% | 48 |
|
|
2019
Q3 | $2.08M | Buy |
25,865
+2,212
| +9% | +$177K | 0.61% | 42 |
|
|
2019
Q2 | $1.89M | Buy |
23,653
+376
| +2% | +$28.8K | 0.53% | 52 |
|
|
2019
Q1 | $1.85M | Buy |
23,277
+13,166
| +130% | +$985K | 0.57% | 44 |
|
|
2018
Q4 | $737K | Buy |
+10,111
| New | +$714K | 0.34% | 60 |
|
Other funds holding MRK
ATO
SlateStone Wealth's MRK Position: Q2 2026 in Review
SlateStone Wealth reduced its Merck (MRK) stake by 4% in Q2 2026, selling an estimated $578K and leaving 117,597 shares worth $15.1M. The position accounts for 1.16% of the portfolio, ranked #23.
SlateStone Wealth first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- SlateStone Wealth held 117,597 shares of Merck worth $15.1M as of Q2 2026.
- SlateStone Wealth sold 4,937 Merck shares in Q2 2026, an estimated $578K.
- Merck made up 1.16% of SlateStone Wealth's portfolio in Q2 2026, its #23 holding.
- SlateStone Wealth first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on SlateStone Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.